Page 8 - Superkine Immunotherapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Superkine immunotherapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Superkine Immunotherapies Today - Breaking & Trending Today

Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights

Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Superkine Immunotherapies , Tony Russo , Elizabeth Williams , Superkine Program , Trademark Office , Medicenna Therapeutics Corp , Meeting Of The International Cytokine Interferon Society , Society For Immunotherapy Of Cancer , Oppenheimer Co , Drug Administration , Reports Fiscal Year , Fahar Merchant , United States Patent , American Association , Annual Meeting , International Cytokine , Orphan Drug , Annual Report , Chief Financial Officer , Russo Partners ,

Medicenna Announces Upcoming Presentation at the AACR Annual Meeting

TORONTO and HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage… ....

New York , United States , Orange County Convention Center , Elizabeth Williams , Superkine Immunotherapies , Medicenna Therapeutics Corp , American Association For Cancer Research , National Post , Postmedia Network Inc , Medicenna Announces Upcoming Presentation , Medicenna Therapeutics , American Association , Cancer Research , Annual Meeting , New York Times , Postmedia Network , Street East , Receptor Selective Superkine , Targeted Delivery , Oncolytic Viruses , Anticancer Vaccines , Orphan Drug , Annual Information Form , Annual Report , Chief Financial Officer , Managing Director ,

Medicenna to Present at the Oppenheimer 33rd Annual Healthcare Conference

Medicenna to Present at the Oppenheimer 33rd Annual Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Elizabeth Williams , Superkine Immunotherapies , Medicenna Therapeutics Corp , Fahar Merchant , Annual Healthcare Conference , Annual Healthcare , Investor Relations , Orphan Drug , Chief Financial Officer , Investor Contact , Dan Ferry , Managing Director , Lifesci Advisors , Medicenna Therapeutics ,

Medicenna Establishes At-the-Market Sales Facility

Medicenna Establishes At-the-Market Sales Facility
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Elizabeth Williams , Superkine Immunotherapies , Oppenheimer Co , Exchange Commission , Syndicate Prospectus Department , Medicenna Therapeutics Corp , Toronto Stock Exchange , Company United States , Nasdaq Capital Market , Registration Statement , Sales Agreement , Orphan Drug , Annual Information Form , Annual Report , Chief Financial Officer , Investor Contact , Dan Ferry , Managing Director , Lifesci Advisors , Medicenna Therapeutics ,

Medicenna Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Medicenna Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Elizabeth Williams , Superkine Immunotherapies , Medicenna Therapeutics Corp , Nasdaq Stock Market , Nasdaq Listing Rule , Minimum Bid Requirement , Minimum Bid , Nasdaq Listing , Orphan Drug , Chief Financial Officer , Investor Contact , Dan Ferry , Managing Director , Lifesci Advisors , Medicenna Therapeutics ,